Click for best price
Human Gene Therapy Market Size, Share 2024
Report Overview:
Gene therapy isa medical approach that treats or prevents disease by correcting the underlying genetic problem. Gene therapy techniques allow doctors to treat a disorder by altering a person's genetic makeup instead of using drugs or surgery.
The Global Human Gene Therapy Market Size was estimated at USD 5383.35 million in 2023 and is projected to reach USD 7766.98 million by 2029, exhibiting a CAGR of 6.30% during the forecast period.
This report provides a deep insight into the global Human Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter?s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Gene Therapy market in any manner.
Global Human Gene Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biogen
Sarepta Therapeutics
Gilead Sciences
Amgen
Novartis
Orchard Therapeutics
Spark Therapeutics
Agc Biologics
Anges
Bluebird Bio
Jazz Pharmaceuticals
Dynavax Technologies
Human Stem Cells Institute
Sibiono Genetech
Shanghai Sunway Biotech
Uniqure N.V.
Gensight Biologics S.A.
Celgene Corporation
Cellectis
Sangamo Therapeutics
Mustang Bio
AGTC
Poseida Therapeutics
Market Segmentation (by Type)
Non-viral Vectors
Viral Vectors
Market Segmentation (by Application)
Neurological Diseases
Cancer
DMD (Duchenne Muscular Dystrophy)
Hepatological Diseases
Others
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
?
| Report Attributes |
Report Details |
| Report Title |
Global Human Gene Therapy Market Research Report 2024(Status and Outlook) |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
153 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Gene Therapy
1.2 Key Market Segments
1.2.1 Human Gene Therapy Segment by Type
1.2.2 Human Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Gene Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Human Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Gene Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Gene Therapy Market Competitive Landscape
3.1 Global Human Gene Therapy Sales by Manufacturers (2019-2024)
3.2 Global Human Gene Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Gene Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Gene Therapy Sales Sites, Area Served, Product Type
3.6 Human Gene Therapy Market Competitive Situation and Trends
3.6.1 Human Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Gene Therapy Industry Chain Analysis
4.1 Human Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Gene Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Gene Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Gene Therapy Sales Market Share by Type (2019-2024)
6.3 Global Human Gene Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Human Gene Therapy Price by Type (2019-2024)
7 Human Gene Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Gene Therapy Market Sales by Application (2019-2024)
7.3 Global Human Gene Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Human Gene Therapy Sales Growth Rate by Application (2019-2024)
8 Human Gene Therapy Market Segmentation by Region
8.1 Global Human Gene Therapy Sales by Region
8.1.1 Global Human Gene Therapy Sales by Region
8.1.2 Global Human Gene Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Human Gene Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Gene Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Gene Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Gene Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Gene Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Biogen
9.1.1 Biogen Human Gene Therapy Basic Information
9.1.2 Biogen Human Gene Therapy Product Overview
9.1.3 Biogen Human Gene Therapy Product Market Performance
9.1.4 Biogen Business Overview
9.1.5 Biogen Human Gene Therapy SWOT Analysis
9.1.6 Biogen Recent Developments
9.2 Sarepta Therapeutics
9.2.1 Sarepta Therapeutics Human Gene Therapy Basic Information
9.2.2 Sarepta Therapeutics Human Gene Therapy Product Overview
9.2.3 Sarepta Therapeutics Human Gene Therapy Product Market Performance
9.2.4 Sarepta Therapeutics Business Overview
9.2.5 Sarepta Therapeutics Human Gene Therapy SWOT Analysis
9.2.6 Sarepta Therapeutics Recent Developments
9.3 Gilead Sciences
9.3.1 Gilead Sciences Human Gene Therapy Basic Information
9.3.2 Gilead Sciences Human Gene Therapy Product Overview
9.3.3 Gilead Sciences Human Gene Therapy Product Market Performance
9.3.4 Gilead Sciences Human Gene Therapy SWOT Analysis
9.3.5 Gilead Sciences Business Overview
9.3.6 Gilead Sciences Recent Developments
9.4 Amgen
9.4.1 Amgen Human Gene Therapy Basic Information
9.4.2 Amgen Human Gene Therapy Product Overview
9.4.3 Amgen Human Gene Therapy Product Market Performance
9.4.4 Amgen Business Overview
9.4.5 Amgen Recent Developments
9.5 Novartis
9.5.1 Novartis Human Gene Therapy Basic Information
9.5.2 Novartis Human Gene Therapy Product Overview
9.5.3 Novartis Human Gene Therapy Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 Orchard Therapeutics
9.6.1 Orchard Therapeutics Human Gene Therapy Basic Information
9.6.2 Orchard Therapeutics Human Gene Therapy Product Overview
9.6.3 Orchard Therapeutics Human Gene Therapy Product Market Performance
9.6.4 Orchard Therapeutics Business Overview
9.6.5 Orchard Therapeutics Recent Developments
9.7 Spark Therapeutics
9.7.1 Spark Therapeutics Human Gene Therapy Basic Information
9.7.2 Spark Therapeutics Human Gene Therapy Product Overview
9.7.3 Spark Therapeutics Human Gene Therapy Product Market Performance
9.7.4 Spark Therapeutics Business Overview
9.7.5 Spark Therapeutics Recent Developments
9.8 Agc Biologics
9.8.1 Agc Biologics Human Gene Therapy Basic Information
9.8.2 Agc Biologics Human Gene Therapy Product Overview
9.8.3 Agc Biologics Human Gene Therapy Product Market Performance
9.8.4 Agc Biologics Business Overview
9.8.5 Agc Biologics Recent Developments
9.9 Anges
9.9.1 Anges Human Gene Therapy Basic Information
9.9.2 Anges Human Gene Therapy Product Overview
9.9.3 Anges Human Gene Therapy Product Market Performance
9.9.4 Anges Business Overview
9.9.5 Anges Recent Developments
9.10 Bluebird Bio
9.10.1 Bluebird Bio Human Gene Therapy Basic Information
9.10.2 Bluebird Bio Human Gene Therapy Product Overview
9.10.3 Bluebird Bio Human Gene Therapy Product Market Performance
9.10.4 Bluebird Bio Business Overview
9.10.5 Bluebird Bio Recent Developments
9.11 Jazz Pharmaceuticals
9.11.1 Jazz Pharmaceuticals Human Gene Therapy Basic Information
9.11.2 Jazz Pharmaceuticals Human Gene Therapy Product Overview
9.11.3 Jazz Pharmaceuticals Human Gene Therapy Product Market Performance
9.11.4 Jazz Pharmaceuticals Business Overview
9.11.5 Jazz Pharmaceuticals Recent Developments
9.12 Dynavax Technologies
9.12.1 Dynavax Technologies Human Gene Therapy Basic Information
9.12.2 Dynavax Technologies Human Gene Therapy Product Overview
9.12.3 Dynavax Technologies Human Gene Therapy Product Market Performance
9.12.4 Dynavax Technologies Business Overview
9.12.5 Dynavax Technologies Recent Developments
9.13 Human Stem Cells Institute
9.13.1 Human Stem Cells Institute Human Gene Therapy Basic Information
9.13.2 Human Stem Cells Institute Human Gene Therapy Product Overview
9.13.3 Human Stem Cells Institute Human Gene Therapy Product Market Performance
9.13.4 Human Stem Cells Institute Business Overview
9.13.5 Human Stem Cells Institute Recent Developments
9.14 Sibiono Genetech
9.14.1 Sibiono Genetech Human Gene Therapy Basic Information
9.14.2 Sibiono Genetech Human Gene Therapy Product Overview
9.14.3 Sibiono Genetech Human Gene Therapy Product Market Performance
9.14.4 Sibiono Genetech Business Overview
9.14.5 Sibiono Genetech Recent Developments
9.15 Shanghai Sunway Biotech
9.15.1 Shanghai Sunway Biotech Human Gene Therapy Basic Information
9.15.2 Shanghai Sunway Biotech Human Gene Therapy Product Overview
9.15.3 Shanghai Sunway Biotech Human Gene Therapy Product Market Performance
9.15.4 Shanghai Sunway Biotech Business Overview
9.15.5 Shanghai Sunway Biotech Recent Developments
9.16 Uniqure N.V.
9.16.1 Uniqure N.V. Human Gene Therapy Basic Information
9.16.2 Uniqure N.V. Human Gene Therapy Product Overview
9.16.3 Uniqure N.V. Human Gene Therapy Product Market Performance
9.16.4 Uniqure N.V. Business Overview
9.16.5 Uniqure N.V. Recent Developments
9.17 Gensight Biologics S.A.
9.17.1 Gensight Biologics S.A. Human Gene Therapy Basic Information
9.17.2 Gensight Biologics S.A. Human Gene Therapy Product Overview
9.17.3 Gensight Biologics S.A. Human Gene Therapy Product Market Performance
9.17.4 Gensight Biologics S.A. Business Overview
9.17.5 Gensight Biologics S.A. Recent Developments
9.18 Celgene Corporation
9.18.1 Celgene Corporation Human Gene Therapy Basic Information
9.18.2 Celgene Corporation Human Gene Therapy Product Overview
9.18.3 Celgene Corporation Human Gene Therapy Product Market Performance
9.18.4 Celgene Corporation Business Overview
9.18.5 Celgene Corporation Recent Developments
9.19 Cellectis
9.19.1 Cellectis Human Gene Therapy Basic Information
9.19.2 Cellectis Human Gene Therapy Product Overview
9.19.3 Cellectis Human Gene Therapy Product Market Performance
9.19.4 Cellectis Business Overview
9.19.5 Cellectis Recent Developments
9.20 Sangamo Therapeutics
9.20.1 Sangamo Therapeutics Human Gene Therapy Basic Information
9.20.2 Sangamo Therapeutics Human Gene Therapy Product Overview
9.20.3 Sangamo Therapeutics Human Gene Therapy Product Market Performance
9.20.4 Sangamo Therapeutics Business Overview
9.20.5 Sangamo Therapeutics Recent Developments
9.21 Mustang Bio
9.21.1 Mustang Bio Human Gene Therapy Basic Information
9.21.2 Mustang Bio Human Gene Therapy Product Overview
9.21.3 Mustang Bio Human Gene Therapy Product Market Performance
9.21.4 Mustang Bio Business Overview
9.21.5 Mustang Bio Recent Developments
9.22 AGTC
9.22.1 AGTC Human Gene Therapy Basic Information
9.22.2 AGTC Human Gene Therapy Product Overview
9.22.3 AGTC Human Gene Therapy Product Market Performance
9.22.4 AGTC Business Overview
9.22.5 AGTC Recent Developments
9.23 Poseida Therapeutics
9.23.1 Poseida Therapeutics Human Gene Therapy Basic Information
9.23.2 Poseida Therapeutics Human Gene Therapy Product Overview
9.23.3 Poseida Therapeutics Human Gene Therapy Product Market Performance
9.23.4 Poseida Therapeutics Business Overview
9.23.5 Poseida Therapeutics Recent Developments
10 Human Gene Therapy Market Forecast by Region
10.1 Global Human Gene Therapy Market Size Forecast
10.2 Global Human Gene Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Gene Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Human Gene Therapy Market Size Forecast by Region
10.2.4 South America Human Gene Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Gene Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Human Gene Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Gene Therapy by Type (2025-2030)
11.1.2 Global Human Gene Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Gene Therapy by Type (2025-2030)
11.2 Global Human Gene Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Human Gene Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Human Gene Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Human Gene Therapy Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Human Gene Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Gene Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Gene Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Gene Therapy as of 2022)
Table 10. Global Market Human Gene Therapy Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Gene Therapy Sales Sites and Area Served
Table 12. Manufacturers Human Gene Therapy Product Type
Table 13. Global Human Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Gene Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Gene Therapy Market Challenges
Table 22. Global Human Gene Therapy Sales by Type (Kilotons)
Table 23. Global Human Gene Therapy Market Size by Type (M USD)
Table 24. Global Human Gene Therapy Sales (Kilotons) by Type (2019-2024)
Table 25. Global Human Gene Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Human Gene Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Gene Therapy Market Size Share by Type (2019-2024)
Table 28. Global Human Gene Therapy Price (USD/Ton) by Type (2019-2024)
Table 29. Global Human Gene Therapy Sales (Kilotons) by Application
Table 30. Global Human Gene Therapy Market Size by Application
Table 31. Global Human Gene Therapy Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Human Gene Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Human Gene Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Gene Therapy Market Share by Application (2019-2024)
Table 35. Global Human Gene Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Gene Therapy Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Human Gene Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Human Gene Therapy Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Human Gene Therapy Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Human Gene Therapy Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Human Gene Therapy Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Human Gene Therapy Sales by Region (2019-2024) & (Kilotons)
Table 43. Biogen Human Gene Therapy Basic Information
Table 44. Biogen Human Gene Therapy Product Overview
Table 45. Biogen Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Biogen Business Overview
Table 47. Biogen Human Gene Therapy SWOT Analysis
Table 48. Biogen Recent Developments
Table 49. Sarepta Therapeutics Human Gene Therapy Basic Information
Table 50. Sarepta Therapeutics Human Gene Therapy Product Overview
Table 51. Sarepta Therapeutics Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Sarepta Therapeutics Business Overview
Table 53. Sarepta Therapeutics Human Gene Therapy SWOT Analysis
Table 54. Sarepta Therapeutics Recent Developments
Table 55. Gilead Sciences Human Gene Therapy Basic Information
Table 56. Gilead Sciences Human Gene Therapy Product Overview
Table 57. Gilead Sciences Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Gilead Sciences Human Gene Therapy SWOT Analysis
Table 59. Gilead Sciences Business Overview
Table 60. Gilead Sciences Recent Developments
Table 61. Amgen Human Gene Therapy Basic Information
Table 62. Amgen Human Gene Therapy Product Overview
Table 63. Amgen Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Amgen Business Overview
Table 65. Amgen Recent Developments
Table 66. Novartis Human Gene Therapy Basic Information
Table 67. Novartis Human Gene Therapy Product Overview
Table 68. Novartis Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Novartis Business Overview
Table 70. Novartis Recent Developments
Table 71. Orchard Therapeutics Human Gene Therapy Basic Information
Table 72. Orchard Therapeutics Human Gene Therapy Product Overview
Table 73. Orchard Therapeutics Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Orchard Therapeutics Business Overview
Table 75. Orchard Therapeutics Recent Developments
Table 76. Spark Therapeutics Human Gene Therapy Basic Information
Table 77. Spark Therapeutics Human Gene Therapy Product Overview
Table 78. Spark Therapeutics Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Spark Therapeutics Business Overview
Table 80. Spark Therapeutics Recent Developments
Table 81. Agc Biologics Human Gene Therapy Basic Information
Table 82. Agc Biologics Human Gene Therapy Product Overview
Table 83. Agc Biologics Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Agc Biologics Business Overview
Table 85. Agc Biologics Recent Developments
Table 86. Anges Human Gene Therapy Basic Information
Table 87. Anges Human Gene Therapy Product Overview
Table 88. Anges Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Anges Business Overview
Table 90. Anges Recent Developments
Table 91. Bluebird Bio Human Gene Therapy Basic Information
Table 92. Bluebird Bio Human Gene Therapy Product Overview
Table 93. Bluebird Bio Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Bluebird Bio Business Overview
Table 95. Bluebird Bio Recent Developments
Table 96. Jazz Pharmaceuticals Human Gene Therapy Basic Information
Table 97. Jazz Pharmaceuticals Human Gene Therapy Product Overview
Table 98. Jazz Pharmaceuticals Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Jazz Pharmaceuticals Business Overview
Table 100. Jazz Pharmaceuticals Recent Developments
Table 101. Dynavax Technologies Human Gene Therapy Basic Information
Table 102. Dynavax Technologies Human Gene Therapy Product Overview
Table 103. Dynavax Technologies Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Dynavax Technologies Business Overview
Table 105. Dynavax Technologies Recent Developments
Table 106. Human Stem Cells Institute Human Gene Therapy Basic Information
Table 107. Human Stem Cells Institute Human Gene Therapy Product Overview
Table 108. Human Stem Cells Institute Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Human Stem Cells Institute Business Overview
Table 110. Human Stem Cells Institute Recent Developments
Table 111. Sibiono Genetech Human Gene Therapy Basic Information
Table 112. Sibiono Genetech Human Gene Therapy Product Overview
Table 113. Sibiono Genetech Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Sibiono Genetech Business Overview
Table 115. Sibiono Genetech Recent Developments
Table 116. Shanghai Sunway Biotech Human Gene Therapy Basic Information
Table 117. Shanghai Sunway Biotech Human Gene Therapy Product Overview
Table 118. Shanghai Sunway Biotech Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Shanghai Sunway Biotech Business Overview
Table 120. Shanghai Sunway Biotech Recent Developments
Table 121. Uniqure N.V. Human Gene Therapy Basic Information
Table 122. Uniqure N.V. Human Gene Therapy Product Overview
Table 123. Uniqure N.V. Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Uniqure N.V. Business Overview
Table 125. Uniqure N.V. Recent Developments
Table 126. Gensight Biologics S.A. Human Gene Therapy Basic Information
Table 127. Gensight Biologics S.A. Human Gene Therapy Product Overview
Table 128. Gensight Biologics S.A. Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Gensight Biologics S.A. Business Overview
Table 130. Gensight Biologics S.A. Recent Developments
Table 131. Celgene Corporation Human Gene Therapy Basic Information
Table 132. Celgene Corporation Human Gene Therapy Product Overview
Table 133. Celgene Corporation Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Celgene Corporation Business Overview
Table 135. Celgene Corporation Recent Developments
Table 136. Cellectis Human Gene Therapy Basic Information
Table 137. Cellectis Human Gene Therapy Product Overview
Table 138. Cellectis Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Cellectis Business Overview
Table 140. Cellectis Recent Developments
Table 141. Sangamo Therapeutics Human Gene Therapy Basic Information
Table 142. Sangamo Therapeutics Human Gene Therapy Product Overview
Table 143. Sangamo Therapeutics Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Sangamo Therapeutics Business Overview
Table 145. Sangamo Therapeutics Recent Developments
Table 146. Mustang Bio Human Gene Therapy Basic Information
Table 147. Mustang Bio Human Gene Therapy Product Overview
Table 148. Mustang Bio Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 149. Mustang Bio Business Overview
Table 150. Mustang Bio Recent Developments
Table 151. AGTC Human Gene Therapy Basic Information
Table 152. AGTC Human Gene Therapy Product Overview
Table 153. AGTC Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 154. AGTC Business Overview
Table 155. AGTC Recent Developments
Table 156. Poseida Therapeutics Human Gene Therapy Basic Information
Table 157. Poseida Therapeutics Human Gene Therapy Product Overview
Table 158. Poseida Therapeutics Human Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 159. Poseida Therapeutics Business Overview
Table 160. Poseida Therapeutics Recent Developments
Table 161. Global Human Gene Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 162. Global Human Gene Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 163. North America Human Gene Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 164. North America Human Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 165. Europe Human Gene Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 166. Europe Human Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 167. Asia Pacific Human Gene Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 168. Asia Pacific Human Gene Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 169. South America Human Gene Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 170. South America Human Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 171. Middle East and Africa Human Gene Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 172. Middle East and Africa Human Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 173. Global Human Gene Therapy Sales Forecast by Type (2025-2030) & (Kilotons)
Table 174. Global Human Gene Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 175. Global Human Gene Therapy Price Forecast by Type (2025-2030) & (USD/Ton)
Table 176. Global Human Gene Therapy Sales (Kilotons) Forecast by Application (2025-2030)
Table 177. Global Human Gene Therapy Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Human Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Gene Therapy Market Size (M USD), 2019-2030
Figure 5. Global Human Gene Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Human Gene Therapy Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Gene Therapy Market Size by Country (M USD)
Figure 11. Human Gene Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Human Gene Therapy Revenue Share by Manufacturers in 2023
Figure 13. Human Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Gene Therapy Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Gene Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Gene Therapy Market Share by Type
Figure 18. Sales Market Share of Human Gene Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Human Gene Therapy by Type in 2023
Figure 20. Market Size Share of Human Gene Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Human Gene Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Gene Therapy Market Share by Application
Figure 24. Global Human Gene Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Human Gene Therapy Sales Market Share by Application in 2023
Figure 26. Global Human Gene Therapy Market Share by Application (2019-2024)
Figure 27. Global Human Gene Therapy Market Share by Application in 2023
Figure 28. Global Human Gene Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Gene Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Human Gene Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Human Gene Therapy Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Human Gene Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Human Gene Therapy Sales Market Share by Country in 2023
Figure 37. Germany Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Human Gene Therapy Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Human Gene Therapy Sales Market Share by Region in 2023
Figure 44. China Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Human Gene Therapy Sales and Growth Rate (Kilotons)
Figure 50. South America Human Gene Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Human Gene Therapy Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Human Gene Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Human Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Human Gene Therapy Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Human Gene Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Gene Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Gene Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Gene Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Human Gene Therapy Market Share Forecast by Application (2025-2030)
